Biopharma Business

Tag "european regulators"

EU review for Sandoz’ Humira, Remicade biosimilars

    EU review for Sandoz’ Humira, Remicade biosimilars

European regulators have accepted for review Sandoz’ marketing applications for biosimilars to AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab). The company is seeking approval for its biosimilars for use in

Read Full Article

EMA Promotes Understanding and Use of Biosimilars

EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference. In an effort to provide healthcare professionals with information on the science

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements